Product Information
AZELASTIN-FLUTIC 137-50 MCG SPR is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $2.0210 per GM under NDC 00480215757. Its NADAC has been published 48 times since Nov 5, 2025.
FDA first approved this application on Apr 8, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
137; 50 ug/1; ug/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480215757
Classification
Generic
Dosage Form
SPRAY, METERED
Route
NASAL
Effective Date
9/23/2026
Active Ingredients
AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATEApproval Type
Generic (ANDA)
FDA Application
ANDA208436FDA Approved
4/8/2025
TE Code
AB
On Market Since
9/8/2025
Pharmacological Classes
Price Statistics
The NADAC for AZELASTIN-FLUTIC 137-50 MCG SPR has been published 48 times since Nov 5, 2025, and over the history we have for it it has declined 32.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.0210 per GM |
|---|---|
| All-time high | $3.0076 (Nov 12, 2025) |
| All-time low | $2.0210 (Sep 23, 2026) |
| 52-week high | $3.0076 |
| 52-week low | $2.0210 |
| Median price | $2.2901 |
| Average price | $2.4161 |
| Largest weekly change | -9.0% (Mar 18, 2026) |
| Weeks tracked | 48 |
| Tracking since | Nov 5, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Azelastine Hydrochloride and Fluticasone Propionate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AZELASTIN-FLUTIC 137-50 MCG SPR?
The current National Average Drug Acquisition Cost (NADAC) for AZELASTIN-FLUTIC 137-50 MCG SPR, manufactured by Teva Pharmaceuticals USA Inc., is $2.0210 per GM (NDC 00480215757), effective Sep 30, 2026.
How has the price of AZELASTIN-FLUTIC 137-50 MCG SPR changed over time?
Over the history we have for it, the NADAC for AZELASTIN-FLUTIC 137-50 MCG SPR has declined 32.8%. It has been tracked across 48 weekly CMS publications since Nov 5, 2025.
What are the highest and lowest recorded NADAC prices for AZELASTIN-FLUTIC 137-50 MCG SPR?
Since Nov 5, 2025, the NADAC for AZELASTIN-FLUTIC 137-50 MCG SPR has ranged from a low of $2.0210 (Sep 23, 2026) to a high of $3.0076 (Nov 12, 2025), with a median of $2.2901 per GM.
Are there cheaper alternatives to AZELASTIN-FLUTIC 137-50 MCG SPR?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AZELASTIN-FLUTIC 137-50 MCG SPR in a comparable dosage form, but none are currently priced below it.
Who manufactures AZELASTIN-FLUTIC 137-50 MCG SPR?
AZELASTIN-FLUTIC 137-50 MCG SPR (NDC 00480215757) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.